|
| DOE-HDBK-1139/3-2005
Sources11
Consolidated Requirements12, 65, 66
4.7.5
OSHA's Regulated Carcinogens Non-laboratory use of the
29CFR1910.1003;
following 13 carcinogens requires additional training as
29CFR1926.1003-1016
prescribed in sections 4.6.5.1 and 4.6.5.2 below.
Nitrobiphenyl (CAS No.) 92933;
alpha-Naphthylamine, CAS No. 134327;
methyl chloromethyl ether, CAS No. 107302;
3,3'-Dichlorobenzidine (and its salts) CAS No. 91941;
bis-Chloromethyl ether, CAS No. 542881;
beta-Naphthylamine, CAS No. 91598;
Benzidine, CAS No. 92875;
4-Aminodiphenyl, CAS No. 92671;
Ethyleneimine, CAS No. 151564;
beta-Propiolactone, CAS No. 57578;
2-Acetylaminofluorene, CAS No. 53963;
4-Dimethylaminoazo-benezene, CAS No. 60117;
N-Nitrosodimethylamine, CAS No. 62759.
4.7.5.1 Each employee prior to being authorized to enter a
29CFR1910.1003(e)(5)(i)
regulated area (see definition), shall receive a training
and indoctrination program including, but not
necessarily limited to:
4.7.5.1.1 the nature of the carcinogenic hazards of a
29CFR1910.1003(e)(5)(i)(A)
carcinogen addressed by this section,
including local and systemic toxicity;
4.7.5.1.2 the specific nature of the operation involving
29CFR1910.1003(e)(5)(i)(B)
carcinogen addressed by this section that
could result in exposure;
4.7.5.1.3 the purpose for and application of the medical
29CFR1910.1003(e)(5)(i)(C)
surveillance program, including, as
appropriate, methods of self-examination;
4.7.5.1.4 the purpose for and application of
29CFR1910.1003(e)(5)(i)(D)
decontamination practices and purposes;
4.7.5.1.5 the purpose for and significance of emergency
29CFR1910.1003(e)(5)(i)(E)
practices and procedures;
4.7.5.1.6 the employee's specific role in emergency
29CFR1910.1003(e)(5)(i)(F)
procedures;
4.7.5.1.7 specific information to aid the employee in
29CFR1910.1003(e)(5)(i)(G)
recognition and evaluation of conditions and
situations which may result in the release of a
carcinogen addressed by this section;
136
|
Privacy Statement - Press Release - Copyright Information. - Contact Us |